ViroCell Biologics, founded in the UK by a prolific academic viral vector manufacturing team, has officially launched. Viral vectors are the primary delivery method for innovative vaccines such as the Oxford/Astra Zeneca COVID vaccine, as well as ...
Orchard Therapeutics said it intended to use some of the proceeds of an IPO to build a manufacturing facility for its gene therapies program and now it is.